Case report: Term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Advances in cervical cancer management for childbearing women have led to less radical approaches. Use of fertility-sparing treatment to treat small cell neuroendocrine carcinoma (SCNEC) is challenging owing to the aggressive nature of the disease, even in early stage disease. Case presentation: A 25-year-old nulligravida woman presented with malodorous vaginal discharge and was diagnosed to have an exophytic cervical SCNEC. A magnetic resonance image scan showed no evidence of parametrial invasion or distant metastasis. Clinical staging allocated her to stage IB1 disease. She underwent radical abdominal trachelectomy for reproductive purpose. Preoperative and postoperative chemotherapy with ifosfamide/etoposide/cisplatin combining gonadotropin-releasing hormone agonist were administered. She had a spontaneous, uneventful pregnancy and successfully delivered a term baby via cesarean section 7 years after treatment. Conclusion: To our knowledge, we describe the first success in offering a fertility-preserving multimodality strategy to present favorable oncologic, reproductive, and obstetric outcomes in a fertile woman of stage I SCNEC. Individualized multimodality therapy may be utilized in specific patients with early-stage cervical cancer to preserve their fertility.

Original languageEnglish
Article number56
JournalBMC Women's Health
Volume17
Issue number1
DOIs
Publication statusPublished - 2017 Jul 28

Fingerprint

Term Birth
Neuroendocrine Carcinoma
Small Cell Carcinoma
Cervix Uteri
Fertility
Uterine Cervical Neoplasms
Vaginal Discharge
Ifosfamide
Etoposide
Gonadotropin-Releasing Hormone
Cesarean Section
Cisplatin
Obstetrics
Magnetic Resonance Spectroscopy
Therapeutics
Neoplasm Metastasis
Drug Therapy
Pregnancy

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

@article{b99dbc025a7047a389c3c426120cb8bf,
title = "Case report: Term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix",
abstract = "Background: Advances in cervical cancer management for childbearing women have led to less radical approaches. Use of fertility-sparing treatment to treat small cell neuroendocrine carcinoma (SCNEC) is challenging owing to the aggressive nature of the disease, even in early stage disease. Case presentation: A 25-year-old nulligravida woman presented with malodorous vaginal discharge and was diagnosed to have an exophytic cervical SCNEC. A magnetic resonance image scan showed no evidence of parametrial invasion or distant metastasis. Clinical staging allocated her to stage IB1 disease. She underwent radical abdominal trachelectomy for reproductive purpose. Preoperative and postoperative chemotherapy with ifosfamide/etoposide/cisplatin combining gonadotropin-releasing hormone agonist were administered. She had a spontaneous, uneventful pregnancy and successfully delivered a term baby via cesarean section 7 years after treatment. Conclusion: To our knowledge, we describe the first success in offering a fertility-preserving multimodality strategy to present favorable oncologic, reproductive, and obstetric outcomes in a fertile woman of stage I SCNEC. Individualized multimodality therapy may be utilized in specific patients with early-stage cervical cancer to preserve their fertility.",
author = "Pei-Ying Wu and Ya-Min Cheng and New, {Geok Huey} and Cheng-Yang Chou and Chiang, {Chun Ting} and Hung-Wen Tsai and Yu-Fang Huang",
year = "2017",
month = "7",
day = "28",
doi = "10.1186/s12905-017-0404-0",
language = "English",
volume = "17",
journal = "BMC Women's Health",
issn = "1472-6874",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Case report

T2 - Term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix

AU - Wu, Pei-Ying

AU - Cheng, Ya-Min

AU - New, Geok Huey

AU - Chou, Cheng-Yang

AU - Chiang, Chun Ting

AU - Tsai, Hung-Wen

AU - Huang, Yu-Fang

PY - 2017/7/28

Y1 - 2017/7/28

N2 - Background: Advances in cervical cancer management for childbearing women have led to less radical approaches. Use of fertility-sparing treatment to treat small cell neuroendocrine carcinoma (SCNEC) is challenging owing to the aggressive nature of the disease, even in early stage disease. Case presentation: A 25-year-old nulligravida woman presented with malodorous vaginal discharge and was diagnosed to have an exophytic cervical SCNEC. A magnetic resonance image scan showed no evidence of parametrial invasion or distant metastasis. Clinical staging allocated her to stage IB1 disease. She underwent radical abdominal trachelectomy for reproductive purpose. Preoperative and postoperative chemotherapy with ifosfamide/etoposide/cisplatin combining gonadotropin-releasing hormone agonist were administered. She had a spontaneous, uneventful pregnancy and successfully delivered a term baby via cesarean section 7 years after treatment. Conclusion: To our knowledge, we describe the first success in offering a fertility-preserving multimodality strategy to present favorable oncologic, reproductive, and obstetric outcomes in a fertile woman of stage I SCNEC. Individualized multimodality therapy may be utilized in specific patients with early-stage cervical cancer to preserve their fertility.

AB - Background: Advances in cervical cancer management for childbearing women have led to less radical approaches. Use of fertility-sparing treatment to treat small cell neuroendocrine carcinoma (SCNEC) is challenging owing to the aggressive nature of the disease, even in early stage disease. Case presentation: A 25-year-old nulligravida woman presented with malodorous vaginal discharge and was diagnosed to have an exophytic cervical SCNEC. A magnetic resonance image scan showed no evidence of parametrial invasion or distant metastasis. Clinical staging allocated her to stage IB1 disease. She underwent radical abdominal trachelectomy for reproductive purpose. Preoperative and postoperative chemotherapy with ifosfamide/etoposide/cisplatin combining gonadotropin-releasing hormone agonist were administered. She had a spontaneous, uneventful pregnancy and successfully delivered a term baby via cesarean section 7 years after treatment. Conclusion: To our knowledge, we describe the first success in offering a fertility-preserving multimodality strategy to present favorable oncologic, reproductive, and obstetric outcomes in a fertile woman of stage I SCNEC. Individualized multimodality therapy may be utilized in specific patients with early-stage cervical cancer to preserve their fertility.

UR - http://www.scopus.com/inward/record.url?scp=85026428600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026428600&partnerID=8YFLogxK

U2 - 10.1186/s12905-017-0404-0

DO - 10.1186/s12905-017-0404-0

M3 - Article

C2 - 28754175

AN - SCOPUS:85026428600

VL - 17

JO - BMC Women's Health

JF - BMC Women's Health

SN - 1472-6874

IS - 1

M1 - 56

ER -